Sinovac Biotech Ltd. Q3 adjusted earnings of $0.07 per share

Sinovac Biotech Ltd. (SVA) revealed a profit for third quarter that dropped from the same period last year.

The company's bottom line totaled $7.79 million, or $0.06 per share. This compares with $8.86 million, or $0.12 per share, in last year's third quarter.

Excluding items, Sinovac Biotech Ltd. reported adjusted earnings of $6.83 million or $0.07 per share for the period.

The company's revenue for the quarter rose 19.3% to $64.34 million from $53.95 million last year.

Sinovac Biotech Ltd. earnings at a glance:

-Earnings (Q3): $6.83 Mln. vs. $10.53 Mln. last year.
-EPS (Q3): $0.07 vs. $0.14 last year.
-Revenue (Q3): $64.34 Mln vs. $53.95 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT